- This event has passed.
Joint BHPA – BVS-ABR event
Parallel session on the topic RADIATION PROTECTION on Friday afternoon jointly organised by BVS-ABR and BHPA.
Programme:
13h30 Welcome and intro (BVS-ABR)
13h35 UNSCEAR Report: ‘Second Primary Cancer After Radiotherapy’ (Laurence Lebaron-Jacobs, CEA, FR)
14h05 Insight into stereotactic radiotherapy and hadron therapy data by the Belgian Cancer Registry (Nancy Van Damme, Belgian Cancer Registry)
14h35 E2-RADIatE: real world data and alternate methodologies for evidence generation in radiotherapy (Enrico Clementel, EORTC)
15h05 Patient release after therapy with Lu-177 labelled pharmaceuticals in HERCA member states (Marleen Vandecapelle, FANC)
15h30 Break
16h00 From Bench to Bedside: The Authorization Process for FLASH-radiotherapy (Willeke Danckaert, FANC)
16h25 Preliminary results of a survey on the current policy about personal radiation protective equipment (PRPE) in Belgian healthcare institutions (Sandrine Magali Bayart, UGent)
16h40 Case Study: Fertility-Preserving Radiotherapy for Pelvic Sarcoma: Clinical Workflow, Testicular Shielding, and Dose Optimization (Arno Van Der Strieckt, Iridium Netwerk)
17h00 end of the session
This session is eligible for 2 hours of continuous professional development in radiation protection for the prolongation of the certification of Medical Doctors for medical supervision (Art. 75 Royal Decree 20 July 2001).
Depending on the relevance for the personal function, this training session is also eligible as continuous professional development for experts in Health Physics (Art. 73 Royal Decree 20 July 2001).
Consult the full abstract book.
RIZIV-INAMI accreditation was granted with the following details:
Number: 26002507
Date: 30/01/2026
Duration: 3,5 h
CP: 3
BHPA website: https://www.bhpa.eu/symposium2026
Parallel session on the topic RADIATION PROTECTION on Friday afternoon jointly organised by BVS-ABR and BHPA.
Do you want to view the slides of the presentations? Login or join BVS-ABR as a member!
Programme:
13h30 Welcome and intro (BVS-ABR)
13h35 UNSCEAR Report: ‘Second Primary Cancer After Radiotherapy’ (Laurence Lebaron-Jacobs, CEA, FR)
14h05 Insight into stereotactic radiotherapy and hadron therapy data by the Belgian Cancer Registry (Nancy Van Damme, Belgian Cancer Registry)
14h35 E2-RADIatE: real world data and alternate methodologies for evidence generation in radiotherapy (Enrico Clementel, EORTC)
15h05 Patient release after therapy with Lu-177 labelled pharmaceuticals in HERCA member states (Marleen Vandecapelle, FANC)
15h30 Break
16h00 From Bench to Bedside: The Authorization Process for FLASH-radiotherapy (Willeke Danckaert, FANC)
16h25 Preliminary results of a survey on the current policy about personal radiation protective equipment (PRPE) in Belgian healthcare institutions (Sandrine Magali Bayart, UGent)
16h40 Case Study: Fertility-Preserving Radiotherapy for Pelvic Sarcoma: Clinical Workflow, Testicular Shielding, and Dose Optimization (Arno Van Der Strieckt, Iridium Netwerk)
17h00 end of the session
This session is eligible for 2 hours of continuous professional development in radiation protection for the prolongation of the certification of Medical Doctors for medical supervision (Art. 75 Royal Decree 20 July 2001).
Depending on the relevance for the personal function, this training session is also eligible as continuous professional development for experts in Health Physics (Art. 73 Royal Decree 20 July 2001).
RIZIV-INAMI accreditation was granted with the following details:
Number: 26002507
Date: 30/01/2026
Duration: 3,5 h
CP: 3
BHPA website: https://www.bhpa.eu/symposium2026